Results 301 to 310 of about 2,087,074 (350)

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

The impact of NaI(Tl) crystal hydration on gamma camera spectral response and image uniformity. [PDF]

J Appl Clin Med Phys
Eliason G, Silosky MS.
europepmc   +1 more source

Multi‐omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma

Molecular Oncology, EarlyView.
Using multi‐omic characterization, we aimed to identify key regulators specific to squamous cell lung carcinoma (SqCC). SqCC‐specific differentially expressed genes were integrated with metabolics data. High expression of the creatine transporter SLC6A8, along with elevated creatine levels, appeared to be a distinct metabolic feature of SqCC.
Johan Staaf, Daniel Ehinger, Hans Brunnström, Mats Jönsson, Frida Rosengren, Marija Kotevska, Anna Karlsson, Mattias Aine, Christian Frezza, Maria Planck, Elsa Arbajian   +10 more
wiley   +1 more source

Conformal inference for reliable single cell RNA-seq annotation. [PDF]

Bioinformatics
López-De-Castro M, García-Galindo A, González-Gomariz J, Armañanzas R.   +3 more
europepmc   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

A Novel PTS Technique with Side Information Blind Detector Based on Minimized Error Accumulation for PAPR Reduction in Coded Underwater Acoustic OFDM Systems. [PDF]

Sensors (Basel)
Xing S, Wei B, Yu Y, Bai Y, Yin J.
europepmc   +1 more source

Real-time electron spectrometer utilizing a permanent magnet and diode detector array. [PDF]

Med Phys
Heath MW, Matthews KL, Pitcher GM, Hogstrom KR.   +3 more
europepmc   +1 more source

Polycrystalline MAPbI₃ AC-bias direct x-ray detectors for 3D reconstruction. [PDF]

Sci Adv
Zhu Z, Zhao B, Wang J, Gao S, He Y, Liu W, Xu X, Li Y.   +7 more
europepmc   +1 more source

Photon-counting CT in maxillofacial and temporal bone CT-a comparative analysis of image quality and dose with high-end energy-integrating CT systems. [PDF]

Eur Radiol Exp
Layer YC, Mesropyan N, Isaak A, Kravchenko D, Bischoff L, Pieper CC, Kupczyk P, Luetkens JA, Ernst BP, Kuetting D.   +9 more
europepmc   +1 more source

Prospective Comparison of Ultra-high-resolution Photon-counting-detector CT Coronary Angiography versus Conventional CT. [PDF]

Br J Radiol
McCollough CH, Davis A, Weber N, Kasten H, Melka E, Rajendran K, Carter R, Leng S.   +7 more
europepmc   +1 more source